Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients

A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and improve recurrence-free survival in people with lung cancer who are overweight or obese, according to a recently published article in the Journal of the National Cancer Institute. 

Read More